Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
Cancer Lymphoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Lymphoma Therapy Area Pipeline Report contains detailed information on the lymphoma drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by c...
January 2010
229 pages
Cancer Melanoma or Skin Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Melanoma or Skin Cancer Therapy Area Pipeline Report contains detailed information on the melanoma or skin cancer drug pipeline. This report provides insight into the pipeline...
January 2010
514 pages
Cancer Multiple Myeloma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Multiple Myeloma Therapy Area Pipeline Report contains detailed information on the multiple myeloma drug pipeline. This report provides insight into the pipeline status of mul...
January 2010
691 pages
Cancer Non-Hodgkin Lymphoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Non-Hodgkin Lymphoma Therapy Area Pipeline Report contains detailed information on the non-hodgkin lymphoma drug pipeline. This report provides insight into the pipeline statu...
January 2010
701 pages
Cancer Ovarian Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the ovarian cancer drug pipeline. This report provides insight into the pipeline status of ovarian...
January 2010
500 pages
Cancer Pancreatic Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Pancreatic Cancer Therapy Area Pipeline Report contains detailed information on the pancreatic cancer drug pipeline. This report provides insight into the pipeline status of p...
January 2010
426 pages
Cancer Prostate Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the prostate cancer drug pipeline. This report provides insight into the pipeline status of prost...
January 2010
770 pages
Breast Cancer Market– An Analysis
US$ 800.00
... US and Europe. Breast cancer market is comprised of two segments - diagnostic and therapy. The key drivers of breast cancer market are aging population, ... therapy or both are used. The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic ...
January 2010
39 pages
Lung Cancer Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung ... Merck Serono International S.A., Merck & Co.Ltd., Telik, Inc., and Woomera Therapeutics, Inc. Market data and analytics are derived from primary and secondary ...
July 2009
842 pages
Worldwide Cancer Market: Trend Analysis
US$ 800.00
... cancers, new cases and deaths. It also analyzes the global radiation therapy and oncology market. It starts with a discussion of the worldwide diagnosis ... and therapy equipment market and then analyzes cancer drugs market. The report ...
June 2008
25 pages